Penumbra Inc Asset Resilience Ratio

Latest as of June 2026: 22.97%

Penumbra Inc asset resilience ratio. Penumbra Inc (PEN) has an Asset Resilience Ratio of 22.97% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PEN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$453.52 Million
Cash + Short-term Investments

Total Assets

$1.97 Billion
All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Penumbra Inc (2013–2025)

Asset resilience ratio of Penumbra Inc from 2013 to 2025. This chart shows how Penumbra Inc's Asset Resilience Ratio has changed over time. Read PEN total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Penumbra Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Penumbra Inc's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $453.52 Million 22.97%
Total Liquid Assets $453.52 Million 22.97%

Asset Resilience Insights

  • Good Liquidity Position: Penumbra Inc maintains a healthy 22.97% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Penumbra Inc Industry Peers by Asset Resilience Ratio

Compare Penumbra Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
Medical Devices 2.82%
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
Medical Devices 10.74%
TAIDOC TECHNOLOGY CORP
TW:4736
Medical Devices 23.03%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 3.90%

Penumbra Inc Asset Resilience Ratio by Year (2013–2025)

Penumbra Inc asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Penumbra Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 29.83% $544.82 Million $1.83 Billion +7.64pp
2024-12-31 22.18% $340.13 Million $1.53 Billion +3.60pp
2023-12-31 18.58% $289.19 Million $1.56 Billion +4.87pp
2022-12-31 13.72% $188.03 Million $1.37 Billion -6.77pp
2021-12-31 20.48% $254.88 Million $1.24 Billion -11.70pp
2020-12-31 32.18% $264.83 Million $822.98 Million +3.74pp
2019-12-31 28.44% $189.39 Million $665.90 Million -10.57pp
2018-12-31 39.01% $200.89 Million $515.01 Million -6.01pp
2017-12-31 45.02% $214.59 Million $476.67 Million +3.25pp
2016-12-31 41.77% $128.75 Million $308.25 Million -7.22pp
2015-12-31 48.99% $129.26 Million $263.85 Million +9.24pp
2014-12-31 39.75% $48.25 Million $121.38 Million +26.34pp
2013-12-31 13.42% $9.54 Million $71.15 Million --
pp = percentage points

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.57 Billion
Market Cap Rank
#1826 Global
#697 in USA
Share Price
$319.21
Change (1 day)
-0.59%
52-Week Range
$270.55 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more